ArticleCancer research communications2021

The ADAM17-directed Inhibitory Antibody MEDI3622 Antagonizes Radiotherapy-induced VEGF Release and Sensitizes Non-Small Cell Lung Cancer for Radiotherapy.

Fabienne Tschanz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.